No Data
Viatris Issues €650 Million Senior Notes in Europe
Express News | Viatris Prices Offering of €650 Mln of 4.250% Senior Notes Due 2033 - SEC Filing
Express News | Viatris Inc: Files for Euro Denominated Notes Offering, Size Not Disclosed - SEC Filing
Express News | Australia's Tga: Supply Constraints Affecting Creon Units Due to an Unexpected Global Increase in Demand
Express News | Australia's Therapeutic Goods Administration: Viatris Notified US Supply Constraints Affecting Creon 25,000 Unit and Creon 35,000 Unit Capsules Will Continue Until Jan 31, 2027
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)